Finance ForgeBETA
Crear cuenta gratis
1)Empresas2)Rankings3)Iniciar sesión
Finance Forge Terminal v1.49.5
PrivacidadTérminosCookiesAviso Legal
● Connected
TNDM US Equity
TANDEM DIABETES CARE INC
16.45USD▲ 2.11%
Healthcare
Medical Devices
96)Comparar97)Tesis →
Market Cap
$1.1B
Shares Outstanding
70M
Revenue (TTM)
$1.0B
Net Income (TTM)
−$63M
FCF (TTM)
−$27M
— Annual —FY2025
Revenue
$1.0B
Gross Margin
53.8%
Operating Margin
-18.4%
Net Margin
-20.2%
FCF Margin
-2.9%
ROE
-131.9%
ROCE
-29.3%
Net Debt/EBITDA
-1.3×
Current Ratio
2.55
D/E Ratio
2
FCF / Share
-0.43
Book Value / Share
2.23
TNDM US Equity
16.45USD▲ 2.11%
Tesis →

TANDEM DIABETES CARE INC (TNDM): análisis fundamental y valoración

TANDEM DIABETES CARE INC cotiza a 16.45 USD y tiene una capitalización bursátil de $1.1B. En los últimos 12 meses ha facturado $1.0B con un margen de flujo de caja libre del -2.9%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud

Price History
Loading...
Perfil
BolsaNasdaqPaísUnited StatesEmpleados2,500Beta1.66Web↗ www.tandemdiabetes.com

Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. It's flagship products are the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system. The company also sells sin…

Múltiplos de Valoración
P/E (Annual)
—
P/E (TTM)
—
P/FCF (Annual)
—
P/FCF (TTM)
—
EV/EBITDA
—
EV/Revenue
1.3×
P/Sales
1.1×
P/Book
7.4×
Rentabilidad (Último Anual)
Gross Margin
53.8%
Operating Margin
-18.4%
Net Margin
-20.2%
FCF Margin
-2.9%
ROE
-131.9%
ROCE
-29.3%
ROA
-23.2%
Effective Tax Rate
—
Métricas TTM
Revenue TTM
$1.0B
Gross Profit TTM
$583M
Operating Income TTM
−$46M
Net Income TTM
−$63M
FCF TTM
−$27M
EPS TTM
-0.93
Quarters Used
4
TTM Period
2025-09-30 → 2026-06-30
Solidez del Balance
Net Debt
$219M
Net Debt / EBITDA
-1.3×
Debt / Equity
2
Current Ratio
2.55
Interest Coverage
—
Working Capital
$375M
Book Value / Share
2.23
Net Debt / Share
3.15
Crecimiento (YoY)
Revenue YoY
+7.9%
Net Income YoY
-113.2%
FCF YoY
-694.1%
EPS Diluted YoY
-106.8%
Retorno al Accionista
Dividend Yield
—
Payout Ratio
—
FCF / Share
-0.43
CapEx % Revenue
2.0%
Rev / Employee
405,894
Empresas similares
Smart Money
vs Sector: Healthcare (1130 empresas)
MétricaTNDMMediana SectorΔ
Gross Margin53.8%57.0%-3.2%
Operating Margin-18.4%-38.6%+20.2%
Net Margin-20.2%-33.6%+13.4%
FCF Margin-2.9%-13.9%+10.9%
ROE-131.9%-40.4%-91.5%
ROA-23.2%-32.0%+8.8%
Current Ratio2.552.84-0.29
Debt / Equity2.000.28+1.72
Scoring Fundamental
Capital Allocation
5/ 8Moderada
✗FCF+Free cash flow positivo
✗FCFmMargen FCF > 10%
✓DilucSin dilución significativa (< 2%/año en 3 años)
✓Rev↑Revenue CAGR 3 años > 5%
✗ROCERetorno sobre capital empleado > 10%
✓DeudaDeuda neta/EBITDA < 3× (o posición de caja neta)
✓Mg↑Margen operativo ≥ hace 2-3 años (tolerancia -2pp)
✓Inv.R&D + Capex > 3% de revenue (reinversión en el negocio)